Question

Which is the best rationale for monitoring a patient with end stage chronic renal disease for anemia?

A) Anemia is a common side effect of end-stage renal disease (ESRD)
B) To assess the effectiveness of antihypertensive medications
C) To monitor for potential electrolyte imbalances
D) To evaluate the need for changes in the dialysis regimen

Answer 1

Monitoring an ESRD patient for anemia is crucial because the decreased production of erythropoietin in chronic kidney disease causes a reduction in red blood cell count, leading to anemia. Therefore, the correct option is a.

Step-by-step explanation:

The best rationale for monitoring a patient with end-stage chronic renal disease (ESRD) for anemia is because anemia is a common side effect of ESRD. In patients with chronic kidney disease, the kidneys often do not produce enough of the hormone erythropoietin (EPO), which is necessary for the production of red blood cells. This deficiency leads to a decrease in red blood cell count, causing anemia. Therefore, monitoring for anemia is essential to manage this side effect and to potentially administer EPO therapy if needed.